课题基金基金详情
LncRNA-H19/let-7g轴抑制低氧诱导肺动脉高压内皮间质转化的机制研究
结题报告
批准号:
81960015
项目类别:
地区科学基金项目
资助金额:
34.0 万元
负责人:
张卫芳
依托单位:
学科分类:
肺循环与肺血管疾病
结题年份:
2023
批准年份:
2019
项目状态:
已结题
项目参与者:
张卫芳
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
客服二维码
微信扫码咨询
中文摘要
最近认为除PASMCs增殖外,内皮间质转化(EndMT)也是肺动脉高压(PH)血管重构的重要因素。前期我们发现let-7g可抑制PASMCs增殖,然而,其在EndMT中的作用尚无报道。预实验我们通过生物信息学技术发现let-7g与PH时EndMT关系密切;大鼠低氧可下调肺动脉let-7g表达,同时诱导EndMT;肺动脉内皮细胞过表达let-7g能显著抑制低氧诱导的EndMT;lncRNA-H19在低氧大鼠肺动脉中上调且与let-7g靶向结合。据此,我们推测H19/let-7g轴可抑制低氧PH时EndMT。本项目拟通过在体动物与细胞实验相结合,阐明H19/let-7g轴抑制PH时EndMT的作用,并探讨潜在的上游机制(HIF-1α/H19/let-7g通路)及下游机制(let-7g/TGFβRⅠ/Smads/snail通路)。本项目将有助于阐明PH的发病机制,为寻找防治PH的新靶点奠定基础。
英文摘要
Pulmonary hypertension (PH) is characterized by hyperproliferation of pulmonary artery smooth muscle cells (PASMCs) within the vascular wall of resistant pulmonary arteries, leading to vascular lumen occlusion. Recent studies found that not only PASMCs proliferation but also endothelial-mesenchymal transition (EndMT) was the key factor leading to vascular remodeling. Our group found let-7g can inhibited hypoxia-induced PASMCs proliferation. However, the role of let-7g in EndMT remains unknown. Our pilot study for the first time found let-7g associated with EndMT during vascular remodeling in PH by a network-based bioinformatics approach. The expression of let-7g was downregulated in hypoxia-induced PH rats and pulmonary artery endothelial cells (PAECs), and EndMT marker proteins (α-SMA and CD31) were significantly up-regulated in the pulmonary artery intima of hypoxic-induced PH rats, lncRNA-H19 was upregulated in hypoxia-induced PH rats and can targeted let-7g, which implied that H19let-7g axis may suppress EndMT during PH. We will be planning to explore the important potential role of H19/let-7g axis in the EndMT during pulmonary vascular remodeling in PH rats and cultured PAECs. Furthermore, we will investigate the underlying mechanisms responsible for the down-regulation of let-7g in pulmonary artery intima in hypoxia-induced PH rats (focusing on HIF-1α/H19/let-7g) and the downstream signaling that let-7 inhibits EndMT (focusing on let-7g/TGFβRⅠ/Smads/snail). This study will contribute to the understanding of pathogenesis of PH, and provide new strategies to seek for the new drugs directing at let-7 targe may regulate multiple disease pathways in the pulmonary vasculature, but their importance in PH is just beginning to emerge.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
The efficacy and safety of rivaroxaban in coronary artery disease patients with heart failure and sinus rhythm: a systematic review and meta-analysis
利伐沙班治疗伴有心力衰竭和窦性心律的冠心病患者的疗效和安全性:系统评价和荟萃分析
DOI:10.1007/s00228-021-03195-w
发表时间:2021
期刊:European Journal of Clinical Pharmacology
影响因子:2.9
作者:Shan;Jingjing Chen;Gang Xiong;Juan Li;J. Wan;Ye Liu;Ruilai Xu;Weifang Zhang
通讯作者:Weifang Zhang
DOI:10.3892/etm.2020.9604
发表时间:2021-03
期刊:Experimental and therapeutic medicine
影响因子:2.7
作者:Hu F;Li M;Han F;Zhang Q;Zeng Y;Zhang W;Cheng X
通讯作者:Cheng X
DOI:10.1155/2021/5765029
发表时间:2021
期刊:BioMed research international
影响因子:--
作者:Zhang W;Tao Z;Xu F;Diao Q;Li J;Zhou L;Miao Y;Xie S;Wan J;Xu R
通讯作者:Xu R
DOI:10.3760/cma.j.cn114015-20211025-01093
发表时间:2022
期刊:药物不良反应杂志
影响因子:--
作者:杨璐;林环玉;谢珊珊;万瑾瑾;敖检根;张卫芳
通讯作者:张卫芳
DOI:10.12360/cpb202103132
发表时间:2022
期刊:中国药理学通报
影响因子:--
作者:张卫芳;徐菲;陶泽颖;刁倩;谢珊珊;李娟;徐睿来
通讯作者:徐睿来
内皮细胞外泌体lncRNA-H19促低氧诱导肺动脉高压肺血管重构的机制研究
  • 批准号:
    82000062
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    张卫芳
  • 依托单位:
microRNA-let-7在低氧诱导肺高压肺血管重构中的作用及机制研究
  • 批准号:
    81460010
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    50.0万元
  • 批准年份:
    2014
  • 负责人:
    张卫芳
  • 依托单位:
国内基金
海外基金